Invaio Sciences Overview

  • Founded
  • 2018

Founded
  • Status
  • Private

  • Employees
  • 120

Employees
  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $50M

  • Investors
  • 5

Invaio Sciences General Information

Description

Operator of multi-platform technology company intended to solve pressing agriculture, nutrition, and environmental challenges. The company's platform leverages advanced sciences to understand the physiology of insects, and the diverse systems of nature, enabling clients to give a unique angle at reducing the use of pesticides globally and develop technology that's mindful of beneficial, bad for pests, and safer for all.

Contact Information

Website
www.invaio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Agriculture
Other Industries
Biotechnology
Environmental Services (B2B)
Primary Office
  • 75 Moulton Street
  • Cambridge, MA 02138-1127
  • United States
+1 (617) 000-0000

Invaio Sciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Invaio Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - General 13-Oct-2021 $50M 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 25-May-2021 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Feb-2020 $40M $62M 00000 Completed Startup
1. Early Stage VC (Series A) 01-Jan-2018 $22M $22M 0000 Completed Startup
To view Invaio Sciences’s complete valuation and funding history, request access »

Invaio Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A-1 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A 11,298,177 $0.001000 $1 $1 1x $1 20.4%
To view Invaio Sciences’s complete cap table history, request access »

Invaio Sciences Executive Team (8)

Name Title Board Seat Contact Info
Peleg Chevion President & Chief Commercial Officer
Kevin Flynn Chief People Officer
Gerardo Ramos Ph.D Chief Science Officer & Board Member
Kirsty James Chief Communications Officer
Maier Avendaño Ph.D Co-Founder & Head of Platform Development
You’re viewing 5 of 8 executive team members. Get the full list »

Invaio Sciences Board Members (6)

Name Representing Role Since
Ena Cratsenburg Self Board Member 000 0000
Gerardo Ramos Ph.D Invaio Sciences Chief Science Officer & Board Member 000 0000
Hugh Grant Self Board Member 000 0000
Iya Khalil Ph.D Self Board Member 000 0000
Pietro Tataranni MD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Invaio Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Invaio Sciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Bluwave Capital Venture Capital Minority 000 0000 000000 0
Investbridge Capital Venture Capital Minority 000 0000 000000 0
Stage 1 Ventures Venture Capital Minority 000 0000 000000 0
Flagship Pioneering Venture Capital Minority 000 0000 000000 0
To view Invaio Sciences’s complete investors history, request access »